Journal profile · Pharmacology & Pharmacy
Journal of Clinical Pharmacy and Therapeutics
ISSN 0269-4727 · eISSN 1365-2710 · Wiley-Blackwell Publishing Ltd · ENGLAND · Bimonthly · Founded 1987
Journal of Clinical Pharmacy and Therapeutics: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1; subscription journal; APC about USD 2,700; median 217 days to acceptance (99 articles, last 24 months); community-reported acceptance: easy; 52 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Journal of Clinical Pharmacy and Therapeutics is published by Wiley-Blackwell Publishing Ltd and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Pharmaceutical Practices and Patient Outcomes, Pharmaceutical studies and practices and Antibiotics Pharmacokinetics and Efficacy, together about 31% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Journal of Clinical Pharmacy and Therapeutics provides a forum for clinicians, pharmacists and pharmacologists to explore and report on issues of common interest. Journal of Clinical Pharmacy and Therapeutics considers original research and review articles for publication. Papers on evidence-based clinical practice and multidisciplinary collaborative work are particularly welcome. Its scope embraces all aspects of clinical drug development and therapeutics, including: Rational therapeutics Evidence-based practice Safety, cost-effectiveness and clinical efficacy of drugs Drug interactions Clinical impact of drug formulations Pharmacogenetics Personalised, stratified and translational medicine Clinical pharmacokinetics
From the journal's Aims & Scope
Research area (LetPub): Pharmacology & Pharmacy
Editorial board by country: 3 in mainland China (about 16%); most named Mainland China 3, United States 3, India 3, United Kingdom 1, Canada 1 (19 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Pharmaceutical Practices and Patient OutcomesMedicine13.6%
- Pharmaceutical studies and practicesMedicine9.7%
- Antibiotics Pharmacokinetics and EfficacyMedicine7.6%
- Pharmacogenetics and Drug MetabolismPharmacology, Toxicology and Pharmaceutics6%
- Pharmacovigilance and Adverse Drug ReactionsPharmacology, Toxicology and Pharmaceutics5.3%
- Medication Adherence and ComplianceMedicine5%
- Pharmacological Effects and Toxicity StudiesMedicine4%
- Antibiotic Use and ResistanceImmunology and Microbiology3.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
PubMedEmbaseCASCAB AbstractsCINAHLCurrent ContentsPublisher website
Other: EBSCO, ProQuest
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1LetPub ·
- Impact factor (publisher)
- 1.1Publisher website ·
- Impact factor (publisher) 2025
- 1.1Publisher website ·
- CiteScore 2026-06
- 5LetPub ·
- CiteScore (publisher)
- 5Publisher website ·
- CiteScore (publisher) 2025
- 5Publisher website ·
- SJR 2026-06
- 0.54LetPub ·
- SNIP 2026-06
- 0.89LetPub ·
- h-index
- 65LetPub ·
- h-index
- 100OpenAlex ·
- i10-index
- 2,074OpenAlex ·
- 2-year mean citedness
- 0.94OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 49LetPub ·
- Articles per year (publisher)
- 2Publisher website ·
- Articles per year (publisher) 2025
- 49Publisher website ·
- Downloads per year (publisher) 2025
- 499,281Publisher website ·
Articles by year OpenAlex count · 4,588 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 51 | 50 | 5 |
| 2025 | 52 | 51 | 33 |
| 2024 | 48 | 47 | 104 |
| 2023 | 55 | 55 | 144 |
| 2022 | 248 | 122 | 2,580 |
| 2021 | 249 | 185 | 2,898 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
217 daysMedian, submission to acceptance · P25–P75 140 days – 297 days
- Acceptance to online
- median 29 days (99 articles)
- Submission to online
- median 252 days
- Sample
- 99 articles with submission and acceptance dates (100 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 4–8 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Acceptance rate (publisher)
- 15%Publisher website ·
- Acceptance rate (publisher) 2025
- 15%Publisher website ·
- Submission to first decision
- 79 daysPublisher website ·
- Submission to first decision 2025
- 79 daysPublisher website ·
- Submission to acceptance 2025
- 169 daysPublisher website ·
- Acceptance to publication 2025
- 28 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 2,700 / EUR 2,340 / GBP 1,990 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare3 items from the author guidelines
- Abstract
- ≤ 300 words
- Reference style
- Chicago
- First submission
- Free format: the journal's layout is not required
Article types accepted8
- expression of concernExpression of Concern Open access EXPRESSION OF CONCERN: Hydroxychloroquine: Pharmacokinetics and ToxicityLength not stated
- original researchThe journal will consider the following article types: Research articles Research articles should present the results of an original research study. These manus…Length not stated
- research articleThe journal will consider the following article types: Research articles Research articles should present the results of an original research study. These manus…Length not stated
- research articlesResearch articles should present the results of an original research study. These manuscripts should describe how the research project was conducted and provide…Length not stated
- reviewThe journal will consider the following article types: Research articles Research articles should present the results of an original research study. These manus…Length not stated
- review articleThe journal will consider the following article types: Research articles Research articles should present the results of an original research study. These manus…Length not stated
- reviewsA review article provides an overview of the published literature in a particular subject area.Length not stated
- systematic reviewThe journal will consider the following article types: Research articles Research articles should present the results of an original research study. These manus…Length not stated
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Plagiarism, Preprints, Trial registration / reporting guidelines
- Authorship Title and authorship information
The following information should be included: Manuscript title Full author names Full institutional mailing addresses Email addresses Affiliations. The publisher remains neutral with regard to jurisdictional claims in institutional affiliations. Responsibility for affiliations ultimately rests with the author, although the publisher may request changes be made to countries listed in affiliations t…
Source ↗Publisher website ·- Conflicts of interest Conflicts of interest
Manuscripts must not be published, in press, or submitted elsewhere, except preprint servers. Model summary
Authors must declare all relevant interests that could be perceived as conflicting. Authors should explain why each interest may represent a conflict. If no conflicts exist, the authors should state this. Submitting authors are responsible for co-authors declaring their interests. Conflicts of interest (COIs, also known as 'competing interests') occur when issues outside research could be reasonab…
Source ↗Publisher website ·- Data availability Data availability
Data availability statement required with submission. Model summary
Authors must include a data availability statement with their submission. When submitting a manuscript, submitting authors will be asked to select from several pre-written statements or use the text editor to tell us about data availability with regard to their submission. Review our Data Sharing Policy to understand which data availability statement is right for your submission.
Source ↗Publisher website ·- Publication ethics
Human experiments must comply with Declaration of Helsinki (1964). Model summary
For any experiments on humans, all work must be conducted in accordance with the Declaration of Helsinki (1964)
Source ↗Publisher website ·- License & copyright Copyright and permissions
Authors retain the copyright of their manuscripts, and all open access articles are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not speci…
Source ↗Publisher website ·- Open access
Authors retain copyright, open access articles under Creative Commons Attribution License. Model summary
Authors retain the copyright of their manuscripts, and all open access articles are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Source ↗Publisher website ·- Peer review Peer review
Single-anonymized peer review model, for applicable article types. Model summary
The journal follows a single-anonymized peer review model, for applicable article types. Information on the Peer Review model can be found here. Wiley's policy on the confidentiality of the review process is available here. All submitted articles are subject to assessment and peer review to ensure editorial appropriateness and technical correctness. Research published in the journal must be: Scien…
Source ↗Publisher website ·- Plagiarism
Uses iThenticate CrossCheck for plagiarism detection. Model summary
This journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts.
Source ↗Publisher website ·- Preprints Preprints
Preprint servers accepted, does not compromise novelty, preprint should be cited. Model summary
The journal accepts articles previously published on preprint servers, and does not consider this to compromise the novelty of the results. Articles based on content previously made public only on a preprint server, institutional repository, or in a thesis will be considered. The preprint should be cited.
Source ↗Publisher website ·- Trial registration / reporting guidelines Reporting guidelines
Authors are strongly encouraged to use appropriate reporting guidelines when preparing and submitting manuscripts, to maximize transparency and reproducibility. Our editors and reviewers are also encouraged to use them in the review process. Completed checklists should be provided in the supplementary files on submission. We particularly encourage the use of: CONSORT for randomized controlled tria…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley-Blackwell Publishing Ltd
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1987
- ISSN
- 0269-4727
- Electronic ISSN
- 1365-2710
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Journal of Clinical Pharmacy and Therapeutics
What CAS zone is Journal of Clinical Pharmacy and Therapeutics in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Clinical Pharmacy and Therapeutics is in Zone 4 of Medicine, and in Zone 4 of the minor category Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Clinical Pharmacy and Therapeutics?
The latest impact factor listed by LetPub is 1; CiteScore 5, h-index 100.
How long does peer review take at Journal of Clinical Pharmacy and Therapeutics?
Based on the dates recorded on 99 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 217 days (interquartile range 140–297 days); authors report an average review time of 4–8 weeks; the community-reported acceptance is “Easy”; the journal's website gives an acceptance rate of 15% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Journal of Clinical Pharmacy and Therapeutics?
According to the journal's author guidelines: Abstract: ≤ 300 words; Reference style: Chicago; First submission: Free format: the journal's layout is not required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Journal of Clinical Pharmacy and Therapeutics based?
Of the 19 board members whose country the journal's board page names, 3 (about 16%) are in mainland China; the countries named most often are Mainland China (3), United States (3) and India (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Clinical Pharmacy and Therapeutics?
According to LetPub and DOAJ records, Journal of Clinical Pharmacy and Therapeutics is indexed in SCIE and Scopus. The journal's website also lists PubMed, Embase, CAS, CAB Abstracts, CINAHL and Current Contents; that list has not been checked against each database.
Is Journal of Clinical Pharmacy and Therapeutics open access, and what is the APC?
Journal of Clinical Pharmacy and Therapeutics is a subscription journal. APC about USD 2,700.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .